180 Life Sciences Corp. (ATNF )

Currency in USD Disclaimer
$2.13 -$0.18 (-7.75%)
Open 07/12/2024
$2.01
$2.48
$1.31
$21.28

Company brief: 180 LIFE SCIENCES CORP. (ATNF )


1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

ATNF Corporation News

Income Statement